DTAB asks manufacturers of ranitidine to monitor NDMA impurity and reduce shelf life
The Drugs Technical Advisory Board (DTAB) has opined that manufacturers of ranitidine - a drug used to treat indigestion, heartburn and acid reflux - should monitor the N-nitrosodimethylamine (NDMA) impurity levels in the active ingredient and formulation …